Literature DB >> 27980495

Probiotics and Disease: A Comprehensive Summary-Part 1, Mental and Neurological Health.

Keren E Dolan1, Heather J Finley1, Cathleen M Burns1, Margaret G Gasta1, Crystal M Gossard1, Emily C Parker1, Jessica M Pizano1, Christy B Williamson1, Elizabeth A Lipski1.   

Abstract

This article series provides a literature review of the disease-specific probiotic strains studied in published clinical trials in humans and animals. The goal of the series is to provide clinically useful tools. The table designs allow for quick access to supportive data related to disease states and will be helpful as a guide for both researchers and clinicians. This first article (part 1) focuses on mental health and neurological conditions. Future articles in this series will review conditions related to cardiometabolic and fatigue syndromes; ear, nose, throat, respiratory, and infectious diseases; immune and dermatological conditions; cancer, gastrointestinal and genitourinary; followed by an article focused on food-based probiotic strains and nutritional supplements. This literature review is specific to condition, probiotic, and strain and also lists currently available products and foods in which these probiotics can be found. In part 1, we explore the role of probiotics in balancing mental health and neurological issues. Conditions in mental health include anxiety, depression, attention-deficit/hyperactivity disorder, and autism. Neurological conditions include age-related cognitive decline, hepatic encephalopathy, cerebral ischemia and reperfusion, traumatic brain injury, and multiple sclerosis.

Entities:  

Year:  2016        PMID: 27980495      PMCID: PMC5145013     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN: 1546-993X


  28 in total

Review 1.  The gut microbiome and the brain.

Authors:  Leo Galland
Journal:  J Med Food       Date:  2014-12       Impact factor: 2.786

2.  A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial.

Authors:  Anna Pärtty; Marko Kalliomäki; Pirjo Wacklin; Seppo Salminen; Erika Isolauri
Journal:  Pediatr Res       Date:  2015-03-11       Impact factor: 3.756

3.  Ingestion of Lactobacillus strain reduces anxiety and improves cognitive function in the hyperammonemia rat.

Authors:  Jia Luo; Tao Wang; Shan Liang; Xu Hu; Wei Li; Feng Jin
Journal:  Sci China Life Sci       Date:  2014-02-19       Impact factor: 6.038

4.  Benefits of early enteral nutrition with glutamine and probiotics in brain injury patients.

Authors:  Ira S Falcão de Arruda; José E de Aguilar-Nascimento
Journal:  Clin Sci (Lond)       Date:  2004-03       Impact factor: 6.124

5.  Consumption of fermented milk product with probiotic modulates brain activity.

Authors:  Kirsten Tillisch; Jennifer Labus; Lisa Kilpatrick; Zhiguo Jiang; Jean Stains; Bahar Ebrat; Denis Guyonnet; Sophie Legrain-Raspaud; Beatrice Trotin; Bruce Naliboff; Emeran A Mayer
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

6.  Alteration of behavior and monoamine levels attributable to Lactobacillus plantarum PS128 in germ-free mice.

Authors:  Wei-Hsien Liu; Hsiao-Li Chuang; Yen-Te Huang; Chien-Chen Wu; Geng-Ting Chou; Sabrina Wang; Ying-Chieh Tsai
Journal:  Behav Brain Res       Date:  2015-10-29       Impact factor: 3.332

7.  Decreased plasma myeloperoxidase associated with probiotic therapy in autistic children.

Authors:  Anthony J Russo
Journal:  Clin Med Insights Pediatr       Date:  2015-02-03

8.  Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy.

Authors:  Berit Rosche; Jonas Werner; Friderike Joëlle Benzel; Lutz Harms; Heidi Danker-Hopfe; Rainer Hellweg
Journal:  Parasite       Date:  2013-12-19       Impact factor: 3.000

9.  A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome.

Authors:  A Venket Rao; Alison C Bested; Tracey M Beaulne; Martin A Katzman; Christina Iorio; John M Berardi; Alan C Logan
Journal:  Gut Pathog       Date:  2009-03-19       Impact factor: 4.181

10.  Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP.

Authors:  Eleonora Distrutti; Julie-Ann O'Reilly; Claire McDonald; Sabrina Cipriani; Barbara Renga; Marina A Lynch; Stefano Fiorucci
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

View more
  1 in total

Review 1.  Evaluating the Effects of Dietary Interventions on Disease Progression and Symptoms of Adults with Multiple Sclerosis: An Umbrella Review.

Authors:  Abbey R Tredinnick; Yasmine C Probst
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.